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Diabetes Mellitus a prevalent chronic disease that 
affects people from all genders and ages, continues to 
grow exponentially with predictions of nearly 578 
million people affected by 2030. Self-management, 
known to be an essential aspect of any care program, 
can help patients with diabetics to control blood 
glucose and thereby, reduce the impact and likely 
complications. However, self-management to date has 
included the development of digital health solutions 
which have poor sustained uptake. This is primarily 
since such digital solutions have a poor fit with patient 
and clinician needs. In this paper, we propose a digital 
platform for supporting patients with diabetes. The 
proposed platform is a work-in-progress research and 
has been co-designed and co-developed (jointly with 
patients and clinicians) based on design science 
principles and includes key aspects of task-technology 
fit information system theory for further evaluation.  
 
Keywords: Diabetes, self-management, online 
education, Task Technology Fit, Design Principle.  
1. Introduction  
Diabetes (Diabetes Mellitus), a prevalent chronic 
disease that continues to affect people across all 
genders and ages. 425 Million people were affected by 
diabetes (type I and II combined) in 2017 while this 
rapidly increased to 463 Million in 2019 [1]. This 
number is expected to grow to at least 578 million by 
2030 [2] due to a combination of issues including 
drastic change of lifestyle, diet and lack of regular 
exercise [3]. In Australia, as of 2017-18 one in twenty 
Australians (4.9% or over 1.2 million individuals) 
have diabetes and this figure continues to grow [4]. If 
this growth continues, up to 3 million Australians over 
the age of 25 will have diabetes by the year 2025 and 
3.5 million by 2033 (with Type-II diabetes accounting 
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for 85% of all diabetes) [5]. According to recent 
COVID-19 surveillance data reported by centre for 
diseases control (CDC), USA [6] the second most 
common underlying chronic health condition among 
COVID-19 patients was diabetes (30%).  
The complications of diabetes include damage to: 
(i) the large blood vessels leading to heart attack, 
stroke or circulation problems in the lower limbs; (ii) 
the small blood vessels causing problems in the eyes, 
kidneys, feet and nerves and (iii) issues with the skin, 
teeth and gums [7] thus making it an unpleasant 
chronic condition that requires further invasive, 
ongoing and expensive healthcare attention if left 
unchecked. 
A key aspect in treating diabetes and its 
consequences, especially in the absence of any 
effective cure, is maintaining appropriate blood 
glucose levels by focusing on appropriate diet, 
physical activity, necessary medication management 
and regular screening [8]. A fundamental factor in 
adhering to a healthy lifestyle is to empower patients 
with diabetes to actively engage in self-management 
regimens [9]. A good self-management regimen can 
help avoid unnecessary and nasty complications that 
can develop due to uncontrolled diabetes while in 
some cases can even effectively help permanently 
reverse type II diabetes [8]. 
Self-management regimens for diabetes generally 
involve daily monitoring of blood glucose levels and 
blood pressure and keeping these within the patient’s 
target ranges; eating a healthy diet focusing on foods 
with a low glycaemic index (GI); engaging in regular 
physical activity; reducing weight if it is above the 
recommended range and quitting smoking [7]. For 
example, increased physical activity alone is known to 
contribute to 30-50% reduction in the development of 
Type II diabetes [10]. Though self-management 
regimens can produce positive outcomes in managing 





diabetes, based on recent research [9, 11], it has been 
demonstrated that the majority of people with diabetes 
find self-management regimens difficult to follow on 
an on-going basis. 
Consequences of poor self-management regimens 
not only can cause potentially devastating outcomes 
for an individual but also puts enormous pressure on 
the healthcare system [1, 12]; e.g., in Australia, 40% 
($55 billion) of healthcare costs are for chronic 
conditions while $2 billion of that is paid by private 
health insurers. The additional cost incurred by 
individuals and government due to diabetes is 
significant and increases significantly in those patients 
with complications. These costs could be significantly 
reduced by providing patients with a better solution to 
adhere to diabetes self-management routines that can 
prevent the development of diabetes or its 
complications.  
As stated earlier, self-management of diabetes is 
challenging for individuals. A recent survey [11] 
conducted with over 100 patients with diabetes has 
alluded to the need for a technological solution as an 
enabler for better diabetes self-management. Such a 
digital solution could be used also as an intervention 
tool to alleviate the challenges in diabetes self-
management. Hence, there is an immediate need to 
develop technological solutions that can support and 
provide educational reinforcement to people with 
diabetes in self-management.  
While digital health solutions (including a 
plethora of mobile applications) for diabetic self-
management (predominately Type-II) exists it is 
evident from a recent review of such digital solution 
[13, 14] ambiguity among the solutions wide 
variability in key features pose significant difficulties 
for patients when using these solutions. A vast 
majority of these solution have been developed with 
minimal or no consultation with patients and clinicians 
hampering uptake of such solution among larger 
population of patients with diabetes. Further, the 
authors [13] emphasize the need for a co-designed 
solution involving patients, clinicians and policy-
makers.  
Considering the above discussion and to answer 
the research question: “How can we responsibly 
develop an effective technological solution for self-
management of diabetes?”, we present our work-in-
progress research - a Diabetes Self-Management 
Platform. Our proposed platform aims to empower 
patients with a digital solution for better self-                                                                                                                                                                                   
management of diabetes. We opt the design science 
research methodology (DSRM) [15, 16] to co-design 
and co-development the platform. The co-design 
process includes eliciting key requirements from users 
(patients and clinicians) and validating the platform 
design with the users as per DSRM guidelines. 
Furthermore, we use a well-known information system 
theory – Task Technology Fit model [17] as our 
guiding theoretical lens in evaluating the platforms fit 
for the given purpose of empowering patients with 
better self-management of diabetes. 
2. Background 
2.1. Type II Diabetes 
Type II Diabetes, is the most common form of 
diabetes, and it accounts for around 90% of all diabetes 
worldwide [18]. In Type II diabetes, when the body 
cells begin to not respond to insulin, it makes the 
individual insulin resistant, and this state is called 
Hyperglycaemia [10]. There are many similarities 
regarding symptoms between Type I and Type II 
diabetes such as excessive thirst, blurry vision, 
frequent urination, unexplained weight loss etc [10]. 
In other scenarios, it is not uncommon for individuals 
to go completely without symptoms. Such variance in 
the likely hood of diagnosing Type II diabetes at first 
sight has resulted in one-third to one-half of the 
population with Type II diabetes undiagnosed for a 
long period of time [10]. Chances of developing Type 
II diabetes have been strongly correlated with the 
factors such as being overweight (clinical obesity), 
increasing age, ethnicity and many lifestyle factors 
such as physical inactivity, smoking and alcohol 
consumption [10]. 
The recommended treatment for patients 
developing or with Type II diabetes is an effective 
self-management regime that can provide the 
necessary interventions on current lifestyle habits [7]. 
Encouraging and empowering individuals to be more 
physically active, practice healthy diet and provide 
educational reinforcement on an ongoing basis is 
critical for a successful self-management routine [19].  
2.2. Theoretical Framework: Task 
Technology Fit  
The Task Technology Fit (TTF) model [17, 20], is a 
well-known theory that has been used to guide the fit 
for purpose evaluation of information systems. 
According to Goodhue and Thompson [17] – “IT is 
more likely to have a positive impact on individual 
performance and be used if the capabilities of the IT 
match the tasks that the user must perform”(p.216).  
Technology is defined as a technological solution that 
comprises of hardware, software, and data flows to 
facilitate users to accomplish their tasks [17]. The TTF 
model for the whole context refers to the degree which 
a technology assists an individual in performing his or 
her portfolio of tasks [17,19].  
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Some research on TTF [21-25] has been carried 
out on extending the TTF model to the context of 
different information systems such as group support 
system, database management systems, software 
maintenance tools and wireless technology, e-health 
records. For example, [23] considered a fit-viability 
model to study m-commerce applications. In their 
framework, viability measures the readiness of the 
organisation for the technology adoption and 
implementation, and fit measures the capabilities of 
the systems to optimally perform the required tasks 
[22].  Particularly, in [24], Park et.al., illustrated an 
idea on content characteristics as a new determinant of 
fit that can contribute to the explanatory power of the 
TTF model. Content is defined here as all forms of 
knowledge, information, and data [23]. 
Figure 1 identifies factors which help build 
context around the identified tasks. The identified 
factors from a high level are external, organisation 
and individual factors (healthcare professionals and 
patient context). 
External factor (Australian Healthcare Context) 
recognizes the factors that impact all the other 
‘factors’ to follow. The locality of this research is 
within the Australian Healthcare System. This would 
require all parties to comply by the regulations set by 
the Australian Healthcare System, which in return 
effect the fit of all identified tasks and technologies. 
Organisation factors identify influences caused 
by the clinic or hospital. These influences for example 
are things such as operation policies and staff training. 
Where differences in set policies and providing staff 
training will impact the fit of the clinical support task 
and related technology.  
Individual factors are characteristics of the two 
user groups, patient, and healthcare professionals. 
The identified characteristics consider the individuals 
background and capabilities which ultimately 
correlate with their experience regarding medication, 
blood glucose monitoring, fitness performance 
monitoring and nutrition tasks. 
Task and Technology will be measured based on 
[20, 26] and also Fit will be measured by matching the 
requirements of the organisation with the 
functionalities offered by the system e.g. data format, 
operating procedures, and output format as well as 
other successful translative performance factors such 
as timeliness, reliability and accuracy [27]. 
2.3. Methodology - DSRM 
Design Science Research Methodology (DSRM) 
revolves around the aim of building multiple socio-
technical artefacts, which range from software, 
processes, computer algorithms and systems with the 
goal to improve and/or solve the problem at hand [28-
30]. Further, Hevner and Wickramasinghe [31] 
employed DSRM to healthcare contexts, noting the 
importance of the adapting and using of DSRM in 
healthcare contexts when patient-centric solutions are 
a priority. Given this, DSRM was incorporated into 
our methodology. Particularly, we followed the seven 
guidelines proposed by [15] for understanding, 
executing, and evaluating design science research. 
Various studies [32-34] have used these guidelines for 
building algorithms and systems.  
The four-cycle model [16] was utilized to 
compose the actions required for the co-design phases 
of the project. The application of the DSRM model is 
as follows:  
The Change and Impact cycle: ensures that the 
designed solution would be fit for purpose in the 
Australian Healthcare context. Items that were 
considered was the designed solution, the mobile 
devices(s) used and the patients and/or clinicians 
which may use the solution. 
The Relevance Cycle: involves the identification 
of key requirements of the users (patients and 
clinicians) by grasping the problems faced in their 
environment through a range of discussions such as 
interviews, focus groups and other techniques.  
The Co-Design Cycle I, II & III: refers to the 
design and development of any artefacts that are 
produced. Which include items such as the paper 
prototype and diabetes management platform itself. 
This cycle ensures that the artefacts go through a range 
of evaluation strategies which ensure the nature of the 
solution caters the problem domain as intended.  
The Rigor Cycle: enables us to verify and 
populate the knowledge base with our findings and 
contributions to the space. From the artifacts designed 
and developed in prior cycles, we extract the 
contributions which range from scientific theories, 
artefact evaluations – capturing what works and what 
does not, but also experience and expertise [16]. 
 
Figure 1. TTF model adapted for co-designed and co-
developed diabetes self-management platform 
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3. Related Applications 
In the space of digital health applications, there 
are currently more than 300,000 mobile apps available 
for a user to download: with diabetes management 
applications being the most [12]. Out of the 
applications, for this study, we have chosen ten 
applications from both Apple’s App Store and 
Google’s Play Store for analysis. The apps were 
selected based on some key factors. They are I) Total 
user downloads, II) Standard feature set, III) Standout 
unique features, IV) Must have a free tier. With this 
criterion in mind, keywords such as “diabetes”, 
“management”, “self-management”, “adherence” 
were queried in the respective stores. With a select list 
of apps filtering through the set criteria, we further 
manually handpicked ten apps based on positive 
comments and overall higher rating. Further needs to 
be highlighted that since Apple’s App Store does not 
publicly present the total number of application 
downloads, the total number of ratings were taken into 
consideration.  
To manage Type II diabetes, the requirement is to 
follow a healthier lifestyle by controlling a range of 
factors such diet, physical activities, and medications. 
These factors can be extracted to a high-level feature 
set category. The identified common feature sets with 
all the applications can be divided into the following 
categories: Medication, Blood Glucose, Fitness, 
Nutrition and Clinical. Figure 2 provides an overview 
of all the selected apps, and the aggregated results of 
how they performed in each of the feature set 
categories. For each of the feature set category, many 
specific features were identified as key influencer of 
diabetes. These features were averaged to populate 
Figure 2. More detailed analysis on those features can 
be found in the Preliminary Results section 6.2. 
Type II diabetes is typically directly correlated 
with poor lifestyle and nutrition management [18], yet 
none of these applications cater for these areas 
completely. Through a comparative gap analysis, we 
found that there are clear gaps in the areas of Clinical, 
Nutrition and Fitness to be addressed. As there are 
applications such as ‘Glucose buddy diabetes tracker’ 
which cater for Fitness features and ‘Diabetes:M’ that 
comprehensively cover the clinical features, there is 
no single personalised diabetes self-management 
application that covers all the vital features outlined as 
a part of this review. In addition, we found that none 
of these solutions catered for cultural or ethnic 
nuances either. The applications compared in this 
review, was chosen due to popularity and demand; 
however, none of them are linked to any formal 
clinical study and do not contain sufficient clinical 
support features. This further highlights the lack of 
responsible development initiatives put in place while 
designing and developing diabetes self-management 
applications, which could be one of the biggest factors 
around the lack of “completeness” regarding 
application features. Hence, this clearly highlights the 
importance to include the user’s perspective. Thus, we 
take a Design Science Research Methodology 
(DSRM) approach to design and develop a 
personalised diabetes platform validated through 
rigorous evaluation strategies, to address a key void in 
diabetes self-management care support. Figure 2 
depicts the feature set that are best covered by the top 
applications in the current market. The legend for this 
Figure 2 is as follows: Green: All required features 
exist; Orange: Required features partially exist; Red: 
Required features missing without replacement. 
4. Diabetic Self-Management Platform: 
Adopting DSRM for Co-design 
In this section we present the DSRM guidelines 
and DSRM cycles, adapted to the context of 
responsibly designing and developing a diabetic self-
management platform. 
4.1. DSRM Guidelines 
Guideline 1: Design as an Artefact: A diabetes 
management platform which caters for both patients 
and clinicians (e.g. nurses) and allows for self-
management of a patient’s diabetes journey. This 
could strengthen the quality of care and timeliness of 
feedback a patient receives, yet not dramatically 
impact the cost of care delivery. 
Guideline 2: Problem Relevance: Provision of 
continuous and superior monitoring and management 
of diabetes. Regardless of restrictions such as location 
and/or time, the patient and clinicians can access vital 
information promptly, allowing for improved decision 
making in relation to diabetes management; with a 
capable solution which is designed and developed to 
enable self-management of diabetes.  







































MySugr      
Blood Sugar Log      
Glucose Tracker & Diabetic Diary      
Diabetes:M      
Glucose buddy diabetes tracker      
One drop diabetes management      
Blood sugar monitor by Dario      
Blood Glucose Tracker      
forDiabetes:diabetes self-management app      
Glucose – blood sugar tracker (iOS only)      
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Guideline 3: Design Evaluation: Emphasis was 
placed with the conscious integration of potential 
patient users and clinicians at various stages of the 
design and evaluation stages of the solution. Further, 
senior representatives from supporting hospitals were 
consulted to ensure the proposed solution aligned with 
many of the government regulations and requirements 
for technology solutions interacting with patients in 
the context of medical research. Design Evaluation 
was an iterative process which reached completion 
when all parties (legal, clinical, patients etc.) were 
content with the artefact and is fit to serve purpose 
from their regard. 
Guideline 4: Research Contributions: In this 
study, users’ perspectives of the mediating role of the 
solution are explored. 
Guideline 5: Research Rigor: Information 
systems conceptual models and theoretical groundings 
were employed. This allowed for existing chronic 
disease management protocols, healthcare quality and 
safety information were consulted to inform the 
development cycles to allow for a clinical context 
evaluation to take place. 
Guideline 6: Design as a Search Process: For the 
ability to conduct a clinical trial and obtaining 
sensitive patient data, the design was strictly 
monitored to ensure the ethics requirements were met. 
Guideline 7: Communication of Research: (I) 
Internal communication: Present the technology and 
clinically oriented users through focus groups, 
simulations exercises, brainstorming meetings, as well 
as technical and managerial meetings. (II) External 
communication: Progress and findings are to be 
reported in relevant peer review outlets including 
international conferences and professional peer-
reviewed journals in relevant disciplines.  
4.2. DSRM Cycles 
In this section we focus on the adoption and the 
processes of the 4 cycle DSRM [16]. Figure 3 
represents the adapted version of the 4 cycle DSRM, 
where the context is designing, developing, and 
evaluating the diabetes self-management platform. 
4.2.1. Change & Impact (CI) Cycle allows us, 
with the External Environmental Factors (Australian 
Healthcare & Patient Environment) in mind, to 
identify factors which can influence patients and 
clinicians in a wider context. This was achieved by 
collaborating with multiple experienced Australian 
healthcare professionals with foundations in diabetes. 
Further, the CI Cycle, enables the validation of the 
designed artefacts to ensure that the research 
grounding effecting the above-mentioned factors are 
still monitored. This validation also ensures that if any 
core changes are made to the process or state of the 
artefact, the External Environment Factors are re-
evaluated to ensure the solution is fit for purpose. This 
is made possible due to the incorporation of the Design 
Evolution Fitness Model. 
4.2.2. Relevance Cycle Helps with the 
identification of the key requirements that are deemed 
critical for a diabetic self-management solution. We 
started by identifying factors of the Internal 
 
Figure 3. Adapted 4 Cycle DSRM for Diabetes Self-Management Platform 
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Environment which directly influence a diabetes 
platform. The identified factors are: I) Patients with 
diabetes; II) Healthcare professionals; III) Diabetes 
self-management platform (proposed artefact); IV) 
Mobile devices used to interact with the platform. 
A wide range of semi-structured interviews and 
workshops were conducted, with the participation of 
patients with diabetes and healthcare professionals. 
This ensures the identified requirements allow for 
improved management of a patient’s diabetes. This 
cycle, through the incorporation of Design Utility 
Model, ensures the developed platform stays fit for 
purpose. The model enables a verification process 
which involves a join evaluation of the identified 
requirements and the user studies data, once 
conducted. 
In one of the workshops, the group discussion 
adopted a problem-solving strategy ‘Working 
backwards’. As the name suggests, the concept of this 
method is to start off with a large/desired end goal, and 
demystify the steps required to achieve that goal by 
working backwards [35]. This activity was run 
iteratively over a predefined set of key objectives and 
topics that were noted as most important by healthcare 
domain experts. The results are presented in Table 1. 
A wide range of semi-structured interviews and 
workshops were conducted, with the participation of 
patients with diabetes and healthcare professionals 
from a hospital in Victoria, Australia. This ensures the 
identified requirements allow for improved 
management of a patient’s diabetes.  
This cycle, through the incorporation of Design 
Utility Model, ensures the developed platform stays fit 
for purpose. The model enables a verification process 
which involves a join evaluation of the identified 
requirements and the user studies data, once 
conducted. 
4.2.3. Co-Design Cycles is an interactive iterative 
process. Our project required numerous iterations, but 
they can be split up into three parts. This refers to the 
initial Design, followed by the Development and then 
the rigorous Evaluation of the artefact. 
4.2.3.1. Co-Design Cycle I is the first iteration of 
the design cycle, we development a set of mock-up 
pages. The mock-ups were inspired from various 
sources of existing application designs but were 
carefully adapted to meet the identified requirements 
of the diabetes self-management platform. Mock-up 
designs are presented in Figure 4 & 5. After the 
presentation of the mock-ups to the patients and 
clinicians, a discussion was prompted to better 
understand their thoughts on it (evaluation). 
4.2.3.2. Co-Design Cycle II Interacts with the 
results that were collected from the evaluation 
following Co-Design Cycle I and allow for a revision 
of the original set of mock-ups to be made. The results 
reflected many red & orange dominant sections of 
Figure 2. The evaluations made apparent the lack of 
personalization for both patients and clinicians, and it 
was added. For patients, this focused on features that 
enabled them to set meal preferences regarding their 
diet and exercise. Where in contrast, the clinicians 
Table 1. Clinician & Patient Workshop Requirement 
Identification 
Category Task Solution 
Lifestyle Searching for 
meals 
Ability to find meals 
based of name search. 
Meal plans Picking a meal from a 
defined meal plan. 
View meal 
information 
View ingredients and 
nutrition information of a 
selected meal. 




Ability to set culture 
specific cuisines and 
other preferences as 
priority during search. 
Log fitness 
activities 
Add any physical activity 





Add any medication 
taken for a given day. 
Resources Type II 
diabetes 
information 
Provide FAQ information 






Provide contact details of 




To view how the patient 
is tracking with their 
diabetes journey. 







Ability to log mmol\L 
levels at a given time. 
View blood 
sugar in an 
interactive 
chart 
A line chart which 
contains all the blood 








identified the need of a simple visualization, which 
graphed the patient’s glucose levels over a timeseries. 
A paper prototype was built in this cycle. This 
prototype acted as the successor to the revised mock-
ups and addressed all the quires brought up during the 
evaluation of the previous cycle. The paper protype 
also introduced the User Interface (UI) for the 
platform in its entirety, in more detail. This also 
prompted a discussion from the patients and clinicians, 
which focused on evaluating the design and functional 
elements. 
4.2.3.3. Co-Design Cycle III Following the paper 
prototype evaluations with the patients and clinicians, 
the design and the functional flow of the platform was 
finalised. From here, works for the development of the 
functional platform (artefact) was started. Throughout 
the development process, a bi-weekly meeting was 
scheduled with the healthcare professionals and 
stakeholders to provide input of the current state of the 
platform at that given point in time. This further 
ensured that the development process was 
continuously validated, allowing for the artefact to 
address the problem domain as intended. Figure 6 
contains an aspect of the platform, that is designed and 
developed for the patients. 
4.2.3.4. Rigor Cycle Enabled us to view and 
verify our contributions to this domain, ensuring that 
we are building and contributing something novel. Our 
contribution through this project was directed at the 
usage of DSRM & Co-design for responsible design 
and development of a diabetes management platform. 
With that in mind, we were able to validate to further 
validate the UI elements, improved evaluation 
strategies when it comes to evaluating diabetes 
platforms and general contributions to Experience & 
Expertise. 
5. Preliminary Outcome 
Using DSRM for Co-design and Co-development 
proved to be crucial in building the requirements for 
this self-management platform. This accounts for both 
the functional platform and the evaluation purposes. 
5.1. Implementation 
Following the DSRM, we identified the 
implementation for the diabetes self-management 
platform will have to come in two ways. To see that 
there are two very different user groups, patients, and 
healthcare professionals, it was important to limit 
functionality between a clinical user and a general 
user. Hence, through the Relevance cycle, we 
identified each user groups essentially require their 
own implementation. A cross platform mobile 
application for the patients and a web application for 
the healthcare profession (nurse/clinician portal).  
With that in mind, we went ahead and 
implemented a full stack system. For the frontend, the 
platform consists of a cross platform mobile 
application, targeting Android and iOS, built using 
Flutter SDK; and for the nurse/clinician portal, we 
have implemented a single page application (SPA) 
using Vue.js. The two frontend systems are connected 
to a NodeJS application programming interface (API), 
where the emphasis of the design and implementation 
was on speed, robustness, and security. The backend 
connects to a MySQL database which is generated by 
the API. Figure 7 illustrates this structure. 
Further, the mobile application and nurse portal is 
locked and secured. Using a Json Web Token (JWT) 
system with an authentication middleware, checking 
requests, and Argon2 hashing algorithm to handle and 
store passwords in a secure manner. Since we are 
working with sensitive data, the API has been setup to 
produce tokens with ‘8h’ expiration for the mobile 
application and ‘30d’ expiration for the nurse/clinician 
portal. This will require users to login into the 
application with a predefined username and password, 
Figure 5. Mock-up based on inspirations 
 
 




Figure 7. High-level architecture 
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which they can modify after being issued an API 
generated one the first time. 
5.2. Preliminary Findings 
The utilisation of co-design and DSRM together 
provided various improvements to the identification of 
the requirements as well as the strategies used to 
evaluate this platform. The addition of the co-design 
principal, with our adapted DSRM model, we were 
able to integrate clinicians/healthcare professionals 
and patients throughout the DSRM Cycles. This 
allowed for two different perspectives on the same 
platform. The addition of clinicians and healthcare 
professionals results in that the evaluation of the 
platform differs immensely compared to previous 
traditional methods, which would have only had the 
directly affected actor (patients) evaluate the platform. 
The clinicians were able to provide professional and 
clinical input with the identification of key 
requirements and the evaluation of the platform, which 
eliminates any medical or clinical oversights. This also 
means that the platform is built with a clinical 
grounding, with in returns grants the platform to be 
clinically sound and medically safe. 
Another benefit in integrating the two user 
groups, patients, and healthcare professionals, is that 
this further enables us to verify that the diabetes self-
management platform application is inline of the 
user’s expectation. 
Further, this integration process of both 
clinicians/healthcare professionals and patient 
contexts provides the ability to initiate a translation 
process. This involves taking the clinician 
requirements and patients inputs and consolidating 
them into a single unique list of requirements. Which 
will reflect both functional and UI requirements. This 
promises that the final platform will result in a single 
unified, patient-centric self-management solution, 
which is also highly personalised to the user group’s 
needs. By taking the approach of integrating clinical 
and patient contexts with DSRM, we are ensured that 
the platform being designed and developed, is being 
done in a responsible manner. 
Here we discuss further regarding the task and 
technology characteristics, discussed earlier in 
Theoretical Framework: Task Technology Fit section 
2.2. 
We present the identified task and technology 
characteristics for our diabetes self-management 
platform and an evaluation of the fit of how our 
platform compares to the other solutions identified in 
Figure 2. This task list also consistent with DSRM 
Relevance cycle gathered through workshops 
involving patients with diabetes and clinicians. Each 
task contains identified technological characteristics. 
Overall, the comparative gap analysis performed 
in section 3 and figure 2 suggests that most, if not all, 
existing approaches have missed some technologies 
that were noted as key requirements for corresponding 
task. Thus, making clear the importance of taking a 
responsible approach to designing and developing IS 
solutions to minimise these critical oversights. 
5.2.1. Task-1: Medication Management 
• Store medication history: Ability to track any 
intake of medication including dosages by storing 
information of every medication intake.  
• Search medication: Ability to search and select a 
medication from an authentic medication 
database validated by clinicians. 
• Create medication intake: Ability to create a 
medication intake based on customised user input 
(e.g. medication name, dosage). 
Evaluation: 80% of the reviewed applications had 
technology to over store medication history and create 
medication intake. However only 10% supported 
search medication. 
5.2.2. Task-2: Blood Glucose level monitoring 
• Store blood glucose levels: A method to self-
monitor blood glucose with provision to store 
each blood glucose measurement along with time. 
• Visualise blood glucose: Ability to visualise 
previously stored blood glucose data using 
suitable graphs with filtering capability. 
• Goal settings for blood glucose level: Ability to 
set a minimum and maximum value of blood 
glucose level to monitor the progress of diabetes 
management. 
• View statistics of Blood glucose: Ability to view 
insightful information based on the historical 
blood glucose data. 
Evaluation: Blood Glucose level Monitoring task is 
well covered. With 100% - all the reviewed 
applications have technology to support store blood 
glucose level, visualise blood glucose and view 
statistics of blood glucose. Further 80% contained 
technology to support to goal setting for blood glucose 
levels. 
5.2.3. Task-3: Fitness performance monitoring  
• Store fitness activity: A method to keep track and 
store fitness activities. 
• Create personalised activity: Ability to create a 
customised firstness activity with relevant fields 
such as type, duration, and intensity. 
• Estimate fitness performance: A functionality to 
compute fitness performance by estimating total 
calories burned for the planned activities. 
Evaluation: Fitness performance monitoring was 
poorly covered. With only 30% of the reviewed 
applications allowed for you to store fitness activity; 
20% has the technology to create personalised activity 
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and 15% with the technology to estimate fitness 
performance. 
5.2.4. Task-4: Nutrition planner 
• Store nutrition: A method to keep track and store 
of nutritional content intake. 
• Search nutritional contents: Ability to search for 
meals, drinks, snacks etc, through an authentic 
resource using internet search. 
• Create nutritional content: Ability to manually 
create and store consumed meal items. 
• View nutritional information on meals: A feature 
which displays a comprehensive list of nutritional 
information (ingredients, kcal, protein etc.) based 
on a selected meal. 
• Store planned meal: A feature that allows to 
create and store a list of pre-planned meals. 
• Recommend for nutrition: A personalised 
nutrition recommender feature, which suggests 
meals based on a range of parameters (e.g. meal 
preference, calory amount). 
Evaluation: Nutrition planner was represented poorly, 
with clear oversights to some tasks. 65% of the 
reviewed applications has technology to store 
nutrition; 60% contains technology to search 
nutritional contents; 35% contains technology to 
search nutritional contents; 30% contains technology 
to view nutritional information on meals; 5% offering 
technology to store planned meals; 0% - none of the 
reviewed applications had technology to recommend 
for nutrition. 
5.2.5. Task-5: Clinical support 
• Contact support: A method for the patients to 
reach out experts (e.g. diabetes coach) for further 
supports and advices. 
• Remote Monitoring: Ability for clinicians to 
monitor and view the progress of patients using 
remote mechanism (nurse/clinician portal). 
• View assigned individuals’ details: A feature 
which enables the patient or healthcare 
professional to view the details of the individuals 
they are assigned to through the platform. 
Evaluation: Clinical support was almost non-existent. 
With 10% of the reviewed applications offered 
technology for remote monitoring and view assigned 
individual’s details; 20% offered paid technology to 
enable contact support, if not considering paid 
features, then 0% offered this technology.  
6. Conclusion & Future Works 
This work in progress research reported on the 
outcomes of a co-design and co-developed platform 
for self-management of diabetes. Our proposed 
platform was co-designed with patients and clinicians 
and we used the DSR methodology to elicit 
requirements from the users. We then employ TTF 
model to assess and evaluate the “fit for purpose” of 
the developed solution. This far, the research has 
completed validating a paper prototype with clinicians 
and patients. A first iteration of the implemented 
platform presented in the paper has been validated 
with clinicians and as part of our future work outlines 
below, we aim to validate the platform with a cohort 
of patients with diabetes. Next steps include a plan to 
address any gaps found in the nutrition support in the 
platform. Currently, it meets all the basic requirements 
of the users, we plan on making this smart and 
personalised to the user. The aim of this work is to help 
determine whether the platform can provide improved 
and sustained ongoing support, and better glucose 
control, for patients with type 2 diabetes, and nutrition 
is a large part of that. We will also be focusing on 
pilot-testing and evaluating the developed platform to 
establish proof of concept with three target groups of 
patients with type 2 diabetes, drawn from Caucasian, 
Indian and Muslim communities. This choice of 
cohort has been made to allow for diverse diet and 
exercise options to assess the personalisation feature, 
tailored to distinctively diverse ethnic dietary 
practices. We have identified a hospital in Victoria as 
a partner for recruiting patient cohorts. 
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